This deal, a biotech-industry record, gives Amgen a firm footing in the multibillion-dollar market in inflammation control. Immunex's most lucrative product is Enbrel, a treatment for rheumatoid arthritis.(46) Amgen hopes to triple the drug's sales to more than $3 billion by 2005, widening its use to other diseases, such as psoriasis, and overcoming manufacturing constraints that have kept the drug in short supply.
With this takeover, Immunex passes from one parent to another. American Home Products ( AHP) holds 41% of the shares, and has given the firm sales and marketing support. (47)But AHP has been selling down its stake since last year, in part to finance a $3.8 billion settlement of claims against its diet drugs.
(48)Although Amgen calls itself a biotech company, its market capitalisation of around $62 billion makes it larger than Pharmacia and several other well-known mainstream drug companies, traditionally considered the big brothers of biotech. But Amgen likes to think of itself as less bureaucratic and more entrepreneurial than its pharmaceutical brethren, and it is free of such big-pharma woes as imminent patent expiry. (49)However, as Joseph Dougherty, a biotech analyst at Lehman Brothers, points out, Amgen will find it hard to retain the freedom of its nimble youth as it strives to expand its sales by more than 30% a year.
Section Ⅲ Writing
Part A
51. Directions:
Imagine you are a student who wants to apply for the New Star scholarship offered by your university. Write a letter to the person concerned which should include: (1)the purpose of writing the letter;(2) your qualifications for the scholarship;(3) your thanks